Forming effective collaborations is important to IGHI. By working in partnership with leaders in their fields, IGHI can make better-informed decisions and obtain a broader understanding of the issues facing global health today.
Our Visiting Professors are listed below:
Dr Hanan Mohamed Al Kuwari
Her Excellency Dr Hanan Mohamed Al Kuwari is the Minister of Public Health for the State of Qatar and is also the Managing Director of Hamad Medical Corporation (HMC), the main national provider of hospital care.
She has been Managing Director of HMC since 2007 and has led the Corporation in transforming into an integrated academic health system that has achieved numerous international accreditations and awards.
H.E Dr Hanan Mohamed Al Kuwari is a member of the Board of Sidra Medical & Research Center, the Joint Commission International (JCI) Middle East Advisory Council, the Association of Academic Health Centers International (AAHCI) Steering Committee and the Institute of Global Health Innovation and Advisory Board Member of the World innovation Summit for Health (WISH). She is Chairperson of the Qatar Bio-Bank Board.
She holds a PhD in healthcare management from Brunel University in the UK and is a visiting professor at Imperial College in London and has received several awards in recognition of her achievements. She is published in various international journals and often speaks at major international conferences.
Dr Faleh Mohamed Hussain Ali
Dr. Faleh Mohamed Hussain Ali is Assistant Secretary General for Policy Affairs at the Supreme Council of Health, Qatar’s highest health authority. He is also Acting Chief Executive Officer of the National Health Insurance Company, Qatar’s public agency responsible for the implementation and administration of a new national health insurance scheme.
Dr. Faleh has a strong academic interest. He is Visiting Scientist at the Harvard T.H. Chan School of Public Health, and nearing completion of his doctorate of philosophy at Imperial College London. He serves on several academic and scientific groups at Qatar University, Qatar Foundation, and Imperial College London. His main research interests include health financing, and health reform impact assessments.
Prior to turning to administration, Dr. Faleh held several health management and clinical posts in Qatar. After working as an orthopedic surgeon and emergency physician, he served as hospital chief executive officer in the public sector. Dr. Faleh holds a Master of Science in Health Management from Imperial College London, and a Bachelor Degree in Medicine from the Royal College of Surgeons in Ireland.
John Appleby joined the Nuffield Trust as Director of Research and Chief Economist in 2016 following his position at the King’s Fund as Chief Economist, and senior lectureships in health economics at the Universities of East Anglia and Birmingham. After his masters in health economics at the University of York in 1980, he worked in the NHS for seven years in Birmingham and London. For five years he worked for the National Association of Health Authorities (now the NHS Confederation) as manager of the Association’s Central Policy Unit. He has recently moved to the Nuffield Trusts as their Director of Research and Chief Economist.
John has published widely on a range of health care finance and economic issues in books, academic journals, reports, magazines and newspapers. He is a regular columnist for the British Medical Journal. Research include a major study of NHS performance since 2002 with Sir Derek Wanless, published by the King’s Fund, an analysis of the public’s attitudes to the NHS (the British Social Attitudes survey) and an analysis of future prospects for NHS funding written in partnership with the Institute for Fiscal Studies.
As well as his post at the King’s Fund, John is a Visiting Professor at the Department of Economics, City University, London, and at the Institute of Global Innovations at Imperial College London.
John has also acted as an advisor to the UK government and Parliament in various capacities, for example, carrying out a review for Ministers of the future funding needs of Northern Ireland’s health service, and as a task force member for the Marmot Commission on health inequalities; and as a special adviser to the House of Commons Health Select Committee.
Professor Sir Sabaratnam Arulkumaran
Sir Sabaratnam is Professor Emeritus of Obstetrics and Gynaecology, St George’s University of London from Jan 2013 after he retired from his position as Professor & Head of O&G in the same institution from 2001 to 2013. He is also Foundation Professor of O&G, St George’s Medical school, University of Nicosia from 2014 and Visiting Professor, Institute of Global Health Policy Innovation, Imperial College, London from 2012.
He was past President of the FIGO (International Federation of Obstetrics & Gynaecology) – (2012 - 2015); of the British Medical Association (BMA) June 2013- June 2014 and the Royal College of Obstetricians & Gynaecologists (RCOG) of the UK (2007-2010).
He was recipient of an Honorary Doctorate from University of Athens (2009), Colombo (2014), London (2013) and Lund, Sweden (2014) and Hon Fellowships from the American, Pakistan, Sri Lankan, South African, Indian, Australia and NZ colleges of O&G and is an Honorary Member of the Institute of Medicine, National Academy of Sciences, USA (2014).
He was appointed a Knight Bachelor by her Majesty the Queen of the UK in her Birthday Honours List in June 2009 in recognition of his services to medicine and healthcare.
Robert J Bell
Mr Robert J Bell joined the Royal Brompton & Harefield Trust as Chief Executive in March 2005 from the William Osler Health Centre, Ontario, Canada, where he was President and Chief Executive Officer.
He has over 40 years international experience in hospital and health services management.
He is a member of the board of directors of Imperial College Health Partners, the Institute of Cardiovascular Medicine and Science. He is also a member of the Board of Directors of Imperial College Academic Health Sciences Centreand Visiting Professor at the Institute of Global Health Innovations, Imperial College and Chairman of the Association of UK University Hospitals.
He has previously held positions as:
- Vice President, Health Care & Life Sciences Market Sectors, Cap Gemini, Ernst & Young Canada Inc.
- Partner, Ernst & Young and at KPMG (Peat Marwick), Toronto
- Vice President, Hilton Universal Hospitals UK Ltd, London
- Vice President, International Services, Extendicare Inc. (London and Toronto)
- Executive Director of District Health Councils in the Ministry of Health, Ontario
- Treasury board officer, Management Board of Cabinet, Government of Ontario
- Systems engineer, Hospital for Sick Children, Toronto.
Robert has a Bachelor of Applied Science in Industrial Engineering from the University of Toronto and a Master of Public Administration, Queen’s University (Canada)
Dr David Bennett
Dr Bennett served as the Chief Executive of Monitor, the economic regulator of the National Health Service (NHS) in England, for just under six years and was also Chairman during three of those years. In this role, Dr Bennett’s responsibilities included regulating competition in the health sector, alongside the Competition and Markets Authority, setting prices for NHS services, alongside NHS England, and overseeing the 153 NHS foundation trusts with annual revenues of £46 billion. Prior to joining Monitor, Dr Bennett worked for Prime Minister Tony Blair, as Head of the Number 10 Policy Unit. This followed an eighteen-year career with McKinsey & Company, where he was a senior partner.
For the past two years, Dr Bennett has served in multiple non-executive or advisory roles. Currently, he is Chairman of Viapath LLP and Executive Chairman of Four Eyes Insight Ltd.
Dr Jo Boufford
Dr. Boufford is Professor Emeritus of Public Service, Health Policy and Management at the Robert F. Wagner Graduate School of Public Service and Clinical Professor of Pediatrics at New York University School of Medicine. She is Co-Director of the National Program Office of the Robert Wood Johnson Foundation Health and Society Scholars Program. She served as Dean of the Robert F. Wagner Graduate School of Public Service at New York University from June 1997 to November 2002. Prior to that, she served as Principal Deputy Assistant Secretary for Health in the U.S. Department of Health and Human Services (HHS) from November 1993 to January 1997, and as Acting Assistant Secretary from January 1997 to May 1997. While at HHS, she served as the U.S. representative on the Executive Board of the World Health Organization (WHO) from 1994–1997.
Dame Glynis Breakwell
Dame Glynis Breakwell is a psychologist whose research focuses on the psychology of risk perception, communication and management; leadership; and identity processes. Her work has included studies of policy responses to BSE, HIV/AIDS, pandemic influenza, health and safety failures at work, and bioterrorism.
She received her PhD and LLD (Hon) from the University of Bristol and her Doctor of Science from the University of Oxford (where she was a Prize Fellow of Nuffield College). She is a Fellow of the Academy of Social Sciences, Honorary Fellow of the British Psychological Society and Principal Fellow of the Higher Education Academy.
In 2014, the UK Science Council named her one of the 100 leading practising scientists in the United Kingdom. She was made a Dame Commander of the Order of the British Empire in 2012 for her contributions to higher education.
From 2001 to 2018, Dame Glynis was President and Vice-Chancellor of the University of Bath and is an Emeritus Professor there. She has been a Director of Universities UK, the Leadership Foundation for Higher Education (Chairing the Research Panel) and Council member of the Economic and Social Sciences Research Council (Chairing the Research Committee). From 2016-19 Dame Glynis was appointed the Senior Non-Executive Director of National Health Service Improvement in the UK.
Dame Ruth Carnall
Dame Ruth has over 30 years of experience in healthcare with 20 as a chief executive in the NHS covering acute hospitals, mental health and community services and health authorities.
She has worked in senior positions at a local, regional and national level covering operational, strategic and policy roles. Over the last 7 years, Ruth has been responsible for the NHS in London as Chief Executive of NHS London. In this capacity, she has overseen an extensive programme of performance improvement and strategic change.
Prior to joining NHS London, Ruth worked as an independent consultant with public and private sector clients including Department of Health, Monitor, Health Authorities, NHS Trusts and Glaxo as well as the Prime Minister’s Delivery Unit, the Cabinet Office, the Home Office and the Ministry of Justice.
In 2011, Ruth was made a Dame Commander of the British Empire for her achievements in healthcare.
Dr Will Cavendish
Will Cavendish is currently Global Head of Digital Services at Arup, an employee-owned company whose mission is to shape a better world through improving the built environment. Previously he was Applied Strategy Lead at DeepMind, responsible for understanding the groundbreaking developments taking place in Artificial Intelligence, and working with key partners to apply them for public good in areas such as health and energy. Before that he was a senior civil servant, including roles as Director General for Innovation, Growth and Technology at the Department of Health; Director General, International Energy and Climate Change at DECC, and head of the Prime Minister’s Implementation Unit, working directly to David Cameron and Nick Clegg. As a result, he has wide-ranging experience of achieving change in areas such as digital, health, education, international energy and climate change, cybersecurity, growth and innovation. When in government, he also led the creation of the world's first network of What Works Centres, set up to provide proper evidence on effective uses of public money, and pioneered the use of transparency and crowdsourcing in policy making. Will has also served as a World Bank economist; has lectured at Oxford University and Imperial College; has a doctorate in economics; and was made a Companion of the Order of the Bath by the Queen in 2015.
Professor Karl Claxton
Karl Claxton is a Professor in the Department of Economics and Related Studies at the University of York. He is also a Senior Research Fellow in the Centre for Health Economics, University of York.
He was a Harkness Fellow at the Harvard School of Public Health and from 1999 until 2007 he held an adjunct appointment at Harvard as an Assistant Professor of Health and Decision Sciences.
His research interests encompass the economic evaluation of health care technologies.
He has served as a member of the National Institute for Clinical Excellence Appraisal Committee since 1999. He has represented the committee at a number of appeals and was an expert witness for the Institute during the judicial review in 2007. He is a member of the National Decision Support Unit and continues to contribute to the development of guidance for the appraisal of health technologies for NICE. He is a previous co-editor of the Journal of Health Economics
He received a PhD in Economics, a MSc in Health Economics and a BA in Economics all from the University of York.
Professor Tumani Corrah
Professor Tumani Corrah is director of the Africa Research Excellence Fund and the UK Medical Research Council’s Foundation director of Africa Research Development. He is the first Emeritus Director of the UK MRC Gambia Unit. These positions provide Tumani with the ideal platform from which to work with partners to enhance research excellence by supporting emerging and talented African researchers. Tumani’s new role plays to his personal passion for growing a new generation of outstanding, African research leaders working on health challenges in Africa for Africa.
Professor Anthony Culyer
Anthony J Culyer is Emeritus Professor of Economics at York (England); Senior Fellow at the Institute of Health Policy, Management and Evaluation at the University of Toronto; Visiting Professor at Imperial College London, and Chair of the International Decision Support Initiative.
He was the founding Organiser of the UK Health Economists’ Study Group. For 33 years he was the founding Co-Editor, with Joe Newhouse, of Journal of Health Economics. He was founding Vice Chair of the National Institute for Health and Care Excellence (NICE). For many years he was Chair of the Department of Economics & Related Studies at York and, for six of them, was also Deputy Vice-Chancellor.
He is the 2015 recipient of the Baxter Foundation’s William B. Graham Prize for Health Services Research, the 2015 Emmett Hall Laureate and Hall Lecturer, and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Avedis Donabedian Outcomes Research Lifetime Achievement Award.
He has published widely, mostly in health economics. The third edition of his The Dictionary of Health Economics (Edward Elgar) came out in 2014. A collection of his non-technical essays called The Humble Economist is available on-line free of charge.
Sir Andrew Dillon
Sir Andrew Dillon joined the NHS in 1975 and has held a number of senior management positions, including General Manager of the Royal Free Hospital and Chief Executive of St George's Healthcare NHS Trust. He joined the National Institute for Health and Care Excellence as its founding Chief Executive in 1999.
Ian is the Director of the NHS Group, a government initiative within the UK Department of Health, which advises Ministers on their stewardship of the NHS. Ian is also Head of Policy Profession where he leads on improving the quality of policy making across the Department of Health.
He was previously the Chief Policy Adviser on Health to the Prime Minister at No 10 Downing Street. Previous posts within the Department of Health were Director of the Policy Unit, Deputy Director for NHS Performance and Head of Primary Medical Care.
Stephen James Dorrell is a former British Conservative politician. He served as the Member of Parliament for Loughborough between 1979 to 1997 and then for Charnwood from 1997 to 2015.
Dorrell served as Chairman of the House of Commons Health Select Committee from 2010 to 2014.
In the 1990s he was a full member of Prime Minister John Major's Cabinet for almost three years, whilst serving as both Secretary of State for National Heritage and then Secretary of State for Health until the 1997 general election. He was also a Patron of the Tory Reform Group.
He left Parliament in 2014 and is currently Chair of the NHS Confederation and of the European Movement. He is also Chairman of Laing Buisson Ltd, a healthcare market intelligence company, and of its sister company Public Policy Projects Ltd which provides public policy advice.
Philip Dunne has been Member of Parliament for the Ludlow Constituency since May 2005. He spent nine-and-a-half years on the Conservative Front Bench, appointed an Opposition Whip in 2008, then a Government Whip in 2010 before becoming Parliamentary Under-Secretary of State in September 2012. He then became Minister of State at the Ministry of Defence in May 2015, where he was responsible for Defence Procurement. Under Prime Minister Theresa May, Philip was appointed Minister of State for Health at the Department of Health in July 2016, and was reappointed following the General Election on 8th June 2017 until January 2018.
At the Department of Health, Philip supported the Secretary of State with ministerial responsibility for hospitals, workforce, financial performance, special measures, patient safety and maternity, and since June 2017, procurement. He sat on the Department of Health Board and had oversight responsibility for NHS Improvement, the Care Quality Commission, Health Education England and the Human Fertilization and Embryo Authority.
He believes politicians can contribute most to their communities if they have experience of the world beyond politics. He had a 20-year business career before becoming actively involved in politics. He has experience of business both big and small, having worked for investment banks in London, New York and Hong Kong and helping start a bookshop business, Ottakar's, from scratch. He has worked for S.G. Warburg, Phoenix Securities, DLJ, Ruffer, and chaired Baronsmead VCT.
Rachel Dunscombe is the Director of Salford Royal Group and was appointed as CEO of the NHS Digital Academy. She was previously CIO at Bolton FT and is currently Chair of the HIMSS UK Advisory Board. Rachel is working on new research studies to follow the Salford Lung Study and is a member of the KLAS research advisory board. As part of her role at Salford she is delivering the Global Digital Exemplar and two NHS Vanguards. She is also a board member for the ISD network, the north-west professional network for informatics, and a member of US organisation Chime, the professional body for CIOs.
Dr Michael Durkin
Dr Mike Durkin is the National Director of Patient Safety at NHS England. Prior to joining NHS England Mike was the Medical Director of the South of England Strategic Health Authority since 2006. He is the National Clinical Director for Venous Thrombo-Embolism and leads the national VTE Prevention Programme.
He qualified at The Middlesex Hospital and has held research and teaching appointments in London and Bristol. He was appointed to the faculty at Yale University School of Medicine where he was also an Attending Anaesthesiologist. He was Medical Director of Gloucestershire Royal NHS Trust from 1993 to 2002 where he has a consultant post in Anaesthesia. He was appointed as Medical Director and Director of Clinical Quality for Avon, Gloucestershire and Wiltshire Strategic Health Authority in 2002.
Professor Leonard Fass
Professor Leonard Fass has 49 years of experience in medical technology in both R&D and marketing roles mainly in the field of diagnostic imaging.
He was a member of the Executive Board of the UK Bioengineering Society and on several university advisory boards. He has served as a reviewer for multiple national and international research funding agencies. For many years he served on the Business and Industry Advisory Committee to the OECD on Healthcare Policy.
Sir Robert Francis QC
Sir Robert Francis QC is a barrister specialising in medical law, particularly in the areas of clinical negligence, medical and mental health treatment, capacity issues, and professional discipline. He has appeared on behalf of interested parties in inquiries about a number of NHS scandals, including the Royal Liverpool Children’s Inquiry, which led to the Human Tissue Act 2004, and the Bristol Royal Infirmary Inquiry, which resulted in cardiac surgeons in the UK publishing more data on the performance of doctors and hospitals. Sir Robert has also chaired independent inquiries, including the Mid Staffordshire NHS Foundation Trust Public Inquiry and the Freedom to Speak Up Review.
Sir Robert has been a non-executive board member of the Care Quality Commission since June 2014. He has been the President of the Patients Association since November 2013, and is a trustee of the Point of Care Foundation and the Prostate Cancer Research Centre. Sir Robert was knighted in the 2014 Birthday Honours and has been elected to Honorary Fellowships of the Royal College of Anaesthetists, the Royal College of Surgeons (England), and the Royal College of Pathologists.
Professor Glenn Gibson
Professor Gibson has demonstrated significant impact within his profession and work practice as a leader in the field of food microbial sciences. He was responsible for the initiation of the prebiotic concept for gut microflora management through diet. The article which originally coined this term was published in 1995 and is currently the most-cited paper in the Agricultural Sciences field of the ISI Essential Science Indicators (>5000 citations). He has published over 450 research papers and edited eight books.
He is a founder and past president of the International Scientific Association for Probiotics and Prebiotics (ISAPP). ISAPP provides a forum for researchers and food and biopharma industry professionals to exchange research findings leading to further opportunities for collaboration and exploitation of the research.
He is a Board Member of Clasado Advisory Board, Allergy Research Foundation.
He has taken part in many high profile public engagement activities including research being covered by television programmes, international news broadcasters and publications.
Professor Gibson is Professor of Food Microbiology, Head of Food Microbial Sciences at the University of Reading.
Peter Goldsbrough is a senior leader experienced in the private and public sectors. Peter was a Managing Director at The Boston Consulting Group and is now a Senior Advisor to the firm. He is a Non-Executive Director of Imperial College Healthcare NHS Trust and sits on the advisory board of the Education Endowment Foundation. He has previously served on the board of NHS London. He has many years’ experience working with healthcare, pharmaceutical and academic organisations as well as substantial financial management expertise.
Peter advises senior leaders of major organisations in a variety of industrial and service sectors on strategic direction and operational performance. He has specialised in the leadership of large-scale operational and organisational change. His geographic experience covers the UK, Europe, the US, Asia and Australasia.
He was educated at Cambridge University and the Harvard Business School.
Professor Sian Griffiths
Professor Griffiths has demonstrated significant impact within her profession and work practice as a leader in the field of public health.
Sian joined the Chinese University of Hong Kong as Professor of Public Health and Director of the School of Public Health in 2005. She became the Chairman of the Department of Community and Family Medicine in 2006. She qualified as a doctor and held a variety of service posts with academic links at international, national, regional and local level within the UK.
She was Chair of the Association for Public Health, Co-founded the UKPHA and was President of the UK Faculty of Public Health of the Royal Colleges of Physicians from 2001-2004 having held a wide number of professional positions.
She co-chaired the Hong Kong Government’s expert committee into the SARS epidemic in 2003 as well as the monitoring committee. Since coming to Hong Kong, she has worked with HKSAR Government, public health professional organisations and colleagues across the healthcare and academic systems. Her interests are in developing health policy through public health approaches and in developing public health capacity to promote the public’s health.
She is a member of the UK RAE panel for epidemiology and public health, and is a member of the National Health Authority Board of Qatar. She is an Honorary Professor at Peking University, the School of Public Health, also a Technical Advisor to Public Health research in Shenzhen Center for Disease Control and Prevention.
She remains honorary senior clinical lecturer in the Department of Public Health and Primary Care of Oxfor d University with whom the School of Public Health, The Chinese University of Hong Kong maintain links. She plays an active role in public health education and policy development in Hong Kong, including advising the HKSAR Department of Health.
In 2000, she received the OBE for services to public health and was made JP by the HKSAR Government in 2010 for her contribution to health in Hong Kong.
Dr David Halpern
David Halpern is the Chief Executive of the Behavioural Insights Team and Board Director. He has led the team since its inception in 2010. Prior to that, David was the founding Director of the Institute for Government and between 2001 and 2007 was the Chief Analyst at the Prime Minister’s Strategy Unit. Before entering government, David held tenure at Cambridge and posts at Oxford and Harvard. He has written several books and papers on areas relating to behavioural insights and wellbeing, including Social Capital (2005), the Hidden Wealth of Nations (2010), and co-author of the MINDSPACE report. David has recently written a book about the team entitled Inside the Nudge Unit: How Small Changes Can Make a Big Difference.
Dr Felicity Harvey
Dr Felicity Harvey CBE was appointed Director General, Public and International Health in April 2012, retiring in June 2016. Previous roles include Director of the Prime Minister’s Delivery Unit; Head of Medicines, Pharmacy and Industry Group at the Department of Health; Director of Prison Health at HM Prison Service; Head of Quality Management, NHS Executive and Private Secretary to the Chief Medical Officer.
Felicity qualified in medicine in 1980, specialising in medical microbiology. She was seconded to Henley Management College to study for an international MBA. She is an Honorary Fellow of the Royal College of Physicians and a Fellow of the Faculty of Public Health and was appointed CBE in 2008.
Felicity currently holds non-executive directorships for Guys & St Thomas’s NHS Foundation Trust and Mediclinic International PLC. She is also a Trustee for Royal Trinity Hospice and a member of the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme.
Dr Axel Heitmueller
Axel has been involved with Imperial College Health Partners since its conception in 2011 as an Interim Director and joined the Partnership full-time in August 2013 as Director of Strategy and Commerce. As of September 2016 Axel was appointed as Managing Director.
Dr Adam Hill
Adam Hill is a dual-qualified Clinician and Mechanical Engineer, with a career built at the interface of Academia, Industry and Health systems. In recent years, he has founded a successful applied research centre, enveloping an R&D programme with expertise in the optimization of novel products and systems, provided strategic advice to global life science companies on behalf of the British Government, and led the medical function in a multinational, publically-listed Health IT brand.
Recently appointed as the Chief Medical Officer of McLaren Applied Technologies, Adam is focused on applying the company’s deep technical expertise to developing human-centric, data-driven solutions to challenging problems that inhibit the realisation of high quality health outcomes for all.
Adam graduated from Imperial College London as a Medical Doctor with gold medal; during this time, he also earned a PhD in Engineering and attended Business School. Having subsequently graduated from the Royal Military Academy Sandhurst, he received his postgraduate clinical training from the Royal College of Surgeons of England, and professional engineering qualification from the Institution of Mechanical Engineers while in the British Army. In addition, Adam has built a portfolio of over 100 publications, in addition to 12 academic awards and patents.
Phil Hope is a partner in Hope Consultancy and Training that works with health and social care organisations to navigate and work with the changing geography of power in the health and care landscape; and to develop excellent and sustainable services for older people.
Phil is a former Member of Parliament (1997-2010) and served in a number of Ministerial roles with responsibilities for local government, skills, charities, social enterprise and social finance. As Minister of State for Care Services his work included development of the White Paper ‘Building a National Care Service’, the National Dementia Strategy, the National Mental Health Strategy ‘New Horizons’, and the National Autism Strategy.
Since leaving Parliament Phil’s work has included developing personalised care services for older people that integrate NHS, social and voluntary sector services around the needs of individuals; developing the national malnutrition task force; and chairing the Imperial College report ‘Creating Sustainable Health and Care Systems in Ageing Societies’.
Professor Clifford Hughes
Professor Cliff Hughes is the President-elect of the International Society for Quality in Health Care. Until the 31st March 2015 he was the Chief Executive Officer of the Clinical Excellence Commission, a statutory health corporation established in 2004 to build capacity and design programmes to promote and support improvement in quality and safety for health services across NSW. This appointment follows a 25-year career as a cardiothoracic surgeon in Sydney. He has been chairman or member of numerous state and federal committees associated with quality, safety and research in clinical practice for health care services. He has held various positions in the Royal Australasian College of Surgeons, including Senior Examiner in Cardiothoracic Surgery and member of the College Council. In November 2015 he was awarded the Sir Hugh Devine medal, the highest honour awarded a Fellow in his lifetime Professor Hughes has served on four editorial boards and has published widely in books, journals and conference proceedings on cardiothoracic surgery, quality and safety. He has a particular passion for patient based care, better incident management, quality improvement programmes and the development of clinical leaders. He has received a number of awards for his national and international work including an Alumni Award from the University of NSW. He has led five medical teams to China and has performed cardiac surgery in Hong Kong, Singapore, Malaysia, India and Bangladesh. In 1998, he was made an Officer in the Order of Australia (AO) in recognition of his contributions and “service to cardiac surgery, international relationships and the community”. In June 2014, the University of NSW conferred upon him the degree of Doctor of Science, its highest academic award.
Sir Thomas Hughes-Hallett
Former barrister, banker and Chief Executive of Marie Curie Cancer Care, Sir Thomas is the Non-Executive Chair of Cause4 - a social business creating pioneering programmes and fundraising solutions for the charitable sector - and the Chair of Chelsea and Westminster Hospital NHS Foundation Trust.
Sir Thomas has been author of a number of independent reviews including The Philanthropy Review, a Review of End-of-Life Care for Adults and Children and the 2013 ‘Who Will Care?’ report commissioned by Essex County Council on health and social care strategy in Essex.
He also authored ‘Dying Healed: Transforming End-of-Life Care Through Innovation’ for the 2013 World Innovation Summit for Health.
Trustee of The Esmée Fairbairn Foundation and The King’s Fund, Sir Thomas is also Chairman of the End-of-Life Care Implementation Advisory Board.
Awarded a Knighthood in 2012 and a Beacon Fellowship for Philanthropy Advocacy in 2013, Sir Thomas’s passions are philanthropy, innovation, patient-centred healthcare and choral music.
Professor Robert Istepanian
Robert Istepanian is a Visiting Professor at the Institute of Global Health Innovation, Imperial College, and London. He is recognised as one of the leading authorities and pioneer of mobile health and the first scientist to have coined and defined the concept of ‘m-Health’. He is a WHO expert advisor on the global organisation’s Guideline Development Group (GDG) for digital health interventions.
He has held several senior academic and research posts in the UK and Canada. These include professorship of Data Communications for Healthcare and founding Director of the Medical Information and Network Technologies Research Centre (MINT) at Kingston University, London and was a visiting professor at St. George’s Medical School, University of London, the Leverhulme ‘Distinguished visiting fellow at the Centre for Global e-Health Innovation, University of Toronto. He also held senior lectureships in the universities of Portsmouth and Brunel University, UK; and associate professor at Ryerson University, Toronto with adjunct professorship at the University of Western Ontario, Canada.
He served as expert on numerous assessment and peer evaluation panels on digital and mobile healthcare technology funding in UK, Holland, Finland, Ireland, Canada and other EU countries. He also served on the editorial boards of numerous international journals and invited as keynote speaker in many international conferences on mobile and digital healthcare innovations. His publications exceed 200 peer-reviewed publications and books including his recent book on mobile health (m-Health).
Tim Kelsey is an entrepreneur and leading advocate for a popular knowledge revolution in government and public services and an internationally regarded thought leader in data transparency and digital technology, particularly in health.
Tim is a senior leader and manager in both public and private sectors. He was founding CEO of Dr Foster, one of the fastest growing businesses in the UK, and now is a main board director of the NHS, one of the world’s largest organisations, where he designs and implements retail digital and information services.
Edward Kiely is a general paediatric surgeon with over 40 years experience in the specialty in the UK and in Australia. His primary interests are in neonatal, oncological and minimally invasive surgery. He has also taken part in 27 operations to separate conjoined twins. He is also committed to mentoring and teaching the next generation of paediatric surgeons.
Paul F. Levy has had an extensive career as a chief executive and leader of several organizations, from running a world-class teaching hospital to managing the multi-billion dollar clean up of the Boston harbor, hailed as one of the most successful examples of public infrastructure projects in a metropolitan area. He has been an innovative leader, known internationally for pushing the boundaries of transparency in organizational communication and continuous learning. He presently advises corporations around the world on negotiation strategy.
Professor Ric Marshall
Trained as an epidemiologist and clinical psychologist, Professor Marshall was the inaugural Director of Pricing at NHS Improvement. In this position, Professor Marshall worked very closely with the NHS in England to establish the mechanisms for setting national prices for NHS services.
Professor Marshall has a wealth of international experience and has managed and advised on health information development in Azerbaijan, Canada, China, Egypt, Macedonia, Georgia, Germany, Indonesia, Ireland, Kosovo, Lithuania, Malaysia, Mauritius, Moldova, Philippines, Qatar, Romania, Serbia, Slovenia and Turkey.
Professor Marshall has also held the appointment of Adjunct Professor with the Faculty of Health Science at the University of Sydney in Australia, specialising in Health Service Management Information Development.
He is currently collaborating and advising in Health Service innovation and funding reform programs in Botswana, Canada, Egypt, Iran, and Bahrain.
Professor Stephen Matlin
Educated in chemistry at Imperial College London, Stephen worked in academia for over 20 years in medicinal, biological and analytical chemistry. He was Professor of Biological Chemistry at City University London and Warwick University. This was followed by periods as Director of the Health and Education Division in the Commonwealth Secretariat, Chief Education Adviser at the UK Department for International Development and Executive Director of the Global Forum for Health Research, Geneva.
Stephen has served as Kelvin Lecturer of the British Association for the Advancement of Science, Honorary President of the British Association for International and Comparative Education, Vice-President of the Royal Institution, Chair of the Commonwealth Association of Science, Technology and Mathematics Educators and Senior Research Fellow at Oxford University. He was a co-founder and co-chair of Global Health Europe.
He is currently an Adjunct Professor in the Institute of Global Health Innovation, Imperial College London, Secretary and Head of Strategic Development for the International Organization for Chemical Sciences in Development, Senior Fellow in the Global Health Centre at the Graduate Institute of International and Development Studies, Geneva and a member of the Advisory Council of the RISE Institute (Institute for Reconstruction and International Security through Education).
Dr David Mitchell
Dr Mitchell qualified in medicine from Cambridge University and the Middlesex Hospital and went on to train in general and respiratory medicine at the Middlesex, Hammersmith, University College, the London Chest and the Royal Brompton hospitals. He was then appointed as senior lecturer and honorary consultant in respiratory and general medicine to St Mary's Hospital Medical School and later, switched to the NHS. He served as clinical director for medicine before being appointed as medical director to the Trust.
Dr Brendan Moran
Brendan Moran is a Consultant Surgeon and Academic Lead in the Peritoneal Malignancy Unit, Basingstoke, UK. He is a Senior Lecturer, University of Southampton Cancer Sciences Division and currently Vice-President of the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and President from July 2018. He is Past President of the Section of Coloproctology, The Royal Society of Medicine and Executive and Member of Council of the RSM and the ACPGBI. He has delivered 10 named Lectures and over 200 other contributions to International societies.
He established the UK National Peritoneal Malignancy Centre in Basingstoke in 2000 and introduced treatment for peritoneal malignancy to the British Isles. He has developed the service into the largest unit in the world and initiated what is now the Peritoneal Malignancy Institute, Basingstoke. He has published the largest single centre series in the world with reported outcomes on 1200 patients with peritoneal malignancy treated by cytoreductive surgery (CRS) and hyperthermic intra peritoneal chemotherapy (HIPEC) and in 1000 patients with appendix tumours. He is founder member, and senior executive, of the Peritoneal Surface Oncology Group International (PSOGI), a global peritoneal malignancy society. He helped establish and is senior advisor and mentor to the Peritoneal Malignancy Institute, Dublin and was awarded Honorary Fellowship of the Royal College of Surgeons in Ireland in 2017 for services to Irish Surgery. He has helped establish, and is currently Senior Advisor, to the Peritonectomy Service in Royal Prince Alfred Hospital, Sydney
He has also instigated clinical research, and national training programs in rectal cancer and has been convener and lead surgeon for the English Multidisciplinary Team - Total Mesorectal Excision (MDT-TME) program between 2003-06, The English Low Rectal Cancer (LOREC) program from 2010-13 and the Significant Polyp Early Colorectal Cancer (SPECC) program between 2015-17. He helped design and instigate the IMPACT (Improving Management for Patients with Advanced Colorectal Tumours) Program in 2018 which will be delivered to all UK and Ireland Colorectal Cancer MDT’s by 2020.
He was surgical lead for the MERCURY (Magnetic Resonance Rectal Cancer European Equivalence) Study and designed and is surgical lead for the ongoing MERCURY 2 study on low rectal cancer.
He has ongoing interests in clinical research in rectal cancer and peritoneal malignancy and has published over 400 papers in peer reviewed journals. His interests include specialist service development and mentoring and trials in complex surgical interventions.
Michel Mossessian is Design Principal at Mossessian Architecture, an international, award-winning architecture practice. Mossessian Architecture is committed to architecture that adds cultural value and benefits society ‘beyond buildings’.
Michel Mossessian launched the practice in London in 2005 to focus on the demands of complex, high-density urban spaces. His design process is entirely collaborative, alert to the needs of clients and attentive to the requirements of all stakeholders.
His own experience heading design at SOM London involved high level projects in Chicago, New York, Paris, and London, including leading the design team that won the competition for the new NATO Headquarters in Brussels.
Born in Paris, Michel studied Architecture at the Ecole National des Beaux Arts, where he was honoured with the Villa Medici Hors les Murs prize, before choosing to continue crafting his approach at Cooper Union in New York and at the Harvard Graduate School of Design in Cambridge, MA.
Sir David Nicholson
Sir David was appointed Chief Executive of NHS England, formerly known as the NHS Commissioning Board, in October 2011. Up until April 2013, when NHS England took on its full powers, Sir David was also Chief Executive of the National Health Service (NHS) in England, a role he had held since September 2006. Sir David’s career in the NHS spans over 30 years. He started in the service as a management trainee, having graduated from the University of the West of England. He has held senior leadership positions in acute and mental health services, and at four regional health authorities. He was awarded the CBE in 2004 and was knighted in 2010, both for his services to the NHS.
Baroness Lindsay Northover
After an early career in academia, Baroness Lindsay Northover was created a life peer in 2000 and has since been heavily involved in the House of Lords. From 2000 to 2002, she served as the Liberal Democrats Health Spokesperson in the House of Lords, and from 2002 to 2010 as the main frontbench Liberal Democrats Spokesperson on International Development.
In 2010, Baroness Northover was appointed Baroness-in-Waiting (Government Whip) and Spokesperson on International Development, Health, Justice and Women and Equalities, and later covered Education, DCMS and DEFRA (instead of Justice and Health). More recently, Baroness Northover served as the Parliamentary Under Secretary of State for the Department for International Development from November 2014 to May 2015. She is now the Liberal Democrat Principal Parliamentary Spokesperson on International Development.
James O'Shaughnessy served as Parliamentary Under Secretary for Health between 2016 and 2018. In that role, he represented the DHSC in the House of Lords across all health and social care issues. His policy responsibilities included NHS innovation; life sciences and research; tech, digital and data transformation; NHS land and estates; and, preparing the DHSC to leave the European Union. James is a Conservative Life Peer, a former Director of Policy in No.10 Downing Street, and founder of the Floreat Education Academy Trust.
Sir John Oldham
Qualified at Manchester Medical School in 1978 and worked in various teaching hospitals, culminating as a GP trainee in inner city Manchester. He joined Manor House Surgery, Glossop in 1983, and becoming senior partner in 1988.
In 1992, he gained an MBA with Distinction from Manchester Business School; his dissertation was on Continuous Quality Improvement in Primary Health Care. The work in the practice led to him being asked to present a paper to the 1st European Forum on quality improvement in health care, and subsequent invitations to the US and Sweden.
Don Berwick, CEO Institute of Health Care Improvement invited him in 1997, to be on a national project group with the IHI in Boston, U.S.A., looking at redesigning surgery systems in the U.S. This was being done using the Collaborative method, which he then brought back to the UK. He first proposed a primary care collaborative in 1997 and ultimately this led to him being asked to create and head the National Primary Care Development Team, which launched in February 2000.
The Primary Care Collaborative was the largest improvement programme in the world covering 32 million patients in 40 months and delivering 72% improvement in access to GPs and substantial reductions in mortality to patients with CHD. John Oldham also created the concept of the award winning Healthy Communities Collaborative with residents of deprived areas as the improvement team members. This concept spread as Passion for Life throughout Scandinavia. He has also worked in Education, raising performance of underperforming pupils. He was invited by the Australian Government to design and train a team operate a Primary Care collaborative across the whole of Australia, and similarly Saskatchewan in Canada. He is a keynote speaker at many international conferences on quality and safety and has also presented at the World economic Forum in Davos. . He has written a couple of books and numerous articles on quality improvement and large system change, and has been a visiting professor at Vanderbilt University, Tennessee. He was National Clinical Lead for Quality and Productivity at the Department of Health and for 6 years was a member of the National Quality Board, setting the strategic direction for quality and safety in the NHS. He was Chair of Primary Care at the Global Health Forum presided by Lord Ara Darzi, and Chair of Independent Commission on Whole Person Care whose report One Person One Team One System was widely praised. He has recently assisted Norwegian ministers in Health strategy, Primary Care redesign in Sweden and a Maternity review in the NHS. He is also adjunct professor of Global health Innovation at Imperial College London and a non executive Board member of the Care Quality Commission.
In 2000, he received the OBE for services to patients and in 2003 was awarded a knighthood for services to the NHS.
Dr William Owen
Dr William F Owen, Jr, MD, FACP, is an internationally experienced, academic health system leader with a balance of strategic vision and operational accumen. Under the patronage Her Highness Sheikha Moza bint Nasser, wife of the former Emir of Qatar, Dr Owen served as inaugural CEO of Sidra Medical & Research Center from 2012-14. Sidra is a unique tertiary/quaternary care health system for the women and children of the Middle East and North Africa and is Cornell University’s international academic health system affiliate.
Dr Owen’s academic career began as Instructor at Harvard Medical School in 1988, where he rose to Director of the nationally ranked Chronic Kidney Disease Program at Harvard’s Brigham and Women’s Hospital. In 1999, he joined Duke University and became a tenured Professor. At Duke, he was founding Director of a health services research and policy Institute that crossed Departments. From 2002-05, he was global Chief Scientist of Baxter International’s (Fortune 200) renal business and a Senior Scholar in Health Sector Management at Duke’s Fuqua Business School.
Dr Owen became the 10th Chancellor of the Health Science Center and Sr Vice President of Health Affairs at the University of Tennessee in 2005, and so became the first African-American to lead a public flagship, research health system. In 2007, he was appointed 5th President of the University of Medicine and Dentistry of New Jersey, then the US’ largest freestanding health university system and now the academic health system of Rutgers University, The State University of NJ.
Dr Colin Price
Colin Price is the Executive Vice President and Global Managing Partner of the Leadership Consulting Practice and based in Heidrick & Struggles’ London office. Prior to joining Heidrick & Struggles, Colin served as chairman of Co Company, an organisational development consulting firm acquired by Heidrick & Struggles in 2015.
He previously led the worldwide organisation practice at McKinsey & Co. for many years. Colin has consulted with many of the world’s largest organisations and published on important business challenges of organisation health and performance for 25 years. His focus is on developing organisations that can align, execute, and renew better and quicker than competitors. His body of work around building organisational health, purpose, culture, leadership, and capabilities has defined this arena of study and practice. Colin has published widely, and is author and co-author of seven books, including Beyond Performance: How Great Organisations Build Ultimate Competitive Advantage, with Scott Keller of McKinsey & Co. This book draws on the most exhaustive research effort of its kind on organisational effectiveness and change management. The research demonstrates that the health of an organisation is equally as important as its performance.
Dr Julia Riley
Professor Julia Riley is a consultant in Palliative Medicine at The Royal Marsden and the Royal Brompton Hospital, and a senior research fellow at Imperial College London. She is also clinical lead for Coordinate My Care, a clinical service offering urgent care plans to pateitns, that is underpinned by digital technology, sharing the plans with all the urgent care services in real time.
Professor Riley has two main research interests. The first is in the inter-individual variation in patients’ response to opioids. The second is the development of models of end-of-life care that involve a seamless transition between the acute and the community sector, improve quality of life, decrease the number of unnecessary hospital admissions and increase the number of patients being cared for and dying in their preferred place.
Baroness Royall of Blaisdon
In June 2004, Janet Royall was created Baroness Royall of Blaisdon, of Blaisdon in the County of Gloucestershire. In the House of Lords, she became government spokesperson for Health, International Development and Foreign and Commonwealth Affairs.
In January 2008 Baroness Royall was appointed government chief whip in the House of Lords, following the resignation of Lord Grocott. She was appointed a Privy Counsellor later in the year. In October 2008, she was promoted to the cabinet by Gordon Brown, who made her Leader of the House of Lords and Lord President of the Council. In June 2009, Royall was succeeded as Lord President by Lord Mandelson, the Business Secretary, and was appointed Chancellor of the Duchy of Lancaster.
Professor Richard Satava
Richard Satava, MD, FACS, is Professor Emeritus of Surgery, University of Washington Medical Center in Seattle, Washington.
Prior academic positions include Professor of Surgery at Yale University and a military appointment as Professor of Surgery (USUHS) in the Army Medical Corps assigned to General Surgery at Walter Reed Army Medical Center. Government positions included Program Manager of Advanced Biomedical Technology at the Defense Advanced Research Projects Agency (DARPA) for 12 years and Senior Science Advisorat the US Army Medical Research and Materiel Command in Ft. Detrick, Maryland, and Director of the NASA Commercial Space Center for Medical Informatics and Technology Applications at Yale University. Upon completion of military career and government service he had continued clinical medicine at Yale University and University of Washington.
His undergraduate training was at Johns Hopkins University, Medical School at Hahnemann University of Philadelphia, Internship at the Cleveland Clinic, Surgical Residency at the Mayo Clinic, and a Fellowship with a Master of Surgical Research at Mayo Clinic.
He has served on the White House Office of Science and Technology Policy (OSTP) Committee on Health, Food and Safety and was also awarded the prestigious Department of Defense Legion of Merit and Department of Defense Exceptional Service medals as well as awarded the Smithsonian Laureate in Healthcare. He has been a member of numerous committees of the American College of Surgeons (ACS), currently serving on the ACS-Accredited Education Institutes (ACS-AEI). He is a Past President of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES), the Society of Laparoendoscopic Surgeons (SLS), and the Society of Medical Innovation and Therapy (SMIT). He was a member of the National Board of Medical Examiners (NBME) and is currently on Board of many surgical societies and on the editorial board of numerous surgical and scientific journals, and active in a number of surgical and engineering societies.
Dr. Satava was the surgeon on the project that developed the first surgical robot, which later became the DaVinci Surgical Robot. In addition, as a government official, he funded all of the surgical robot development for the first 10 years, until commercialization became possible. For 5 years he was a member of the Advisory Board of the National Space Biomedical Research Institute (NSBRI) advising NASA in surgical robotics, advanced biometric sensing and other life science research for astronauts. Now Dr. Satava has added being continuously active in surgical education and surgical research, with more than 200 publications and book chapters in diverse areas of advanced surgical technology, including Surgery in the Space Environment, Video and 3-D imaging, Plasma Medicine, Directed Energy Surgery, Telepresence Surgery, Robotic Surgery, Virtual Reality Surgical Simulation, Objective Assessment of Surgical Competence and Training and the Moral and Ethical Impact of Advanced Technologies.
During his 23 years of military surgery he has been an active flight surgeon, an Army astronaut candidate, combat tours of duty as MASH surgeon for the Grenada Invasion, and a hospital commander during Desert Storm, all the while continuing clinical surgical practice. Current research is focused on advanced technologies to formulate the architecture for the next generation of clinical Medicine and Surgery, education and training.
Nick Seddon is Senior Vice President and Head of Product at Optum, a leading healthcare company with revenues of over $110 billion. Optum’s product portfolio comprises pharmacy care services, cutting-edge data and analytics, and primary and ambulatory care delivery organizations across the United States. Nick is responsible for product strategy, portfolio management, and growth investments – as well as an increasing focus on applying genomics to clinical practice.
Before joining Optum, Nick served as Special Advisor for Health and Life Sciences for the British Prime Minister David Cameron. In this role, he was a leader in developing and implementing strategies to ensure the long-term sustainability of the UK’s National Health Service, through the development of major initiatives such as the NHS’s 2014 “Five Year Forward View” and the “Seven Day Services” agenda. During the UK’s G8 presidency, Nick worked with the PM and other international stakeholders to bring the fight against dementia to the forefront of the global policy agenda. He also provided day-to-day counsel for the PM on key health care and social services issues.
Prior to his position at 10 Downing Street, Nick was Deputy Director of Reform, a leading think tank focusing on public services and the economy. Previously, he worked at Circle Health, then the UK’s fastest-growing healthcare company, and has authored many publications in national newspapers and journals, as well as a number of books and reports, and appeared frequently on television and radio.
He was educated at Magdalene College, Cambridge. In July 2016 he was awarded an MBE by the Queen. He lives in Minneapolis with his wife Jo and their and three children.
Professor Jeffrey Shaw
Professor Shaw has demonstrated signific ant impact wi thin his profession and work practice as a leader in the field of digital media technologies.
He has been a leading figure in new media art since its emergence from the performance, expanded cinema and installation paradigms of the 1960s to its present day technology-informed and virtualised forms. In a prolific career of widely exhibited and critically acclaimed work, he has pioneered the creative use of digital media technologies in the fields of virtual and augmented reality, immersive visualisation environments, navigable cinematic systems and interactive narrative.
Professor Shaw was co-founder of the Eventstructu re Research Group in Amsterdam ( 1969-1979), a nd founding director of the ZKM Institute for Visual Media Karlsruhe (1991-2002). At the ZKM he conceived and ran a seminal artistic research program that included the ArtIntAct series of digital publications, the MultiMediale series of international media art exhibitions, over one hundred artist-in-residence proj ects, and t he invention of new creative platforms such as the EVE Extended Virtual Environment (1993) PLACE (1995) and the P anoramic Navig ator (1997). In 1995 Shaw was appointed Professor of Media Art at the State University of Design, Media and Arts (HfG), Karlsruhe, Germany.
In 2003, Professor Shaw was awarded the prestigious Australian Research Council Federation Fellowship and returned to Australia to co-found and direct the UNSW iCinema Centre for Interactive Cinema Research in Sydney from 2003-2009. At iCinema he led a theoretical, aesthetic and technological research program in immersive interactive post-narrative systems, which produced pioneering artistic and research works such as Place-Hampi and T_Visionarium, the latter shown at the Biennale of Seville in 2008.
In 2009 he joined City University in Hong Kong as Chair Professor of Media Art and Dean of the School of Creative Media (SCM).
Dr Richard Smith
Richard Smith is Chair of the board of ICDDR,B (formerly International Centre for Diarrhoeal Disease Research, Bangladesh), an Adjunct Professor at Imperial’s Institute of Global Health Innovation, and Chair of the board of Patients Know Best (a company that gathers all patients’ medical and social care records and puts them under the control of the patients), an adviser to F1000Research, which is reinventing the publishing of science, and a manic blogger.
Previously he was Editor of the British Medical Journal and Chief Executive of the BMJ Publishing Group and a television doctor on BBC Breakfast Time and TV-AM.
He likes making porridge, marmalade, soup, and trouble.
Dr Suzanne Suggs
Professor Suggs is an Associate Professor of Social Marketing and Head of the BeCHANGE Research Group in the Institute for Public Communication, Faculty of Communication Sciences, at the University of Lugano in Switzerland. She is also Director of the USI Sustainability Incubator (USI-SINC). She received a BBA in Marketing at University of North Texas (USA), a MSc and PhD in Health Studies at Texas Woman’s University (USA), and a Post-doctoral fellowship at McMaster University (Canada).
Suzanne’s research focuses on behavior change communication through information and communication technologies. She examines the determinants of behavior and tests innovative digital communication strategies, delivered through ICT, and the influence on health behaviors. The majority of her work focuses on eating and physical activity behaviors, but also does research on alcohol, tobacco, decision-making, vaccination uptake, hand washing, HIV testing, medication compliance, self-management of conditions and therapy, and consumption behaviors.
Prior to joining the faculty in Lugano, she was Assistant Professor of Health Communication, Department of Marketing Communication, at Emerson College and Adjunct Assistant Clinical Professor in the Department of Public Health and Family Medicine at Tufts University School of Medicine (Boston, Massachusetts, USA).
Dr Suggs is also Associate Editor of Global Health Communication and on the Editorial Review Board of the Journal of Health Communication.
Professor Matthew Swindells
Professor Matthew Swindells has worked his whole career in healthcare. He currently runs his own consultancy business MJS Healthcare Consulting and is working with a number of global organisations to develop their long-term healthcare strategies, as well as continuing to support NHS organisations with digitally enabled system transformation.
Prior to this, he was Deputy Chief Executive of NHS England. In this role, he led the NHS's commissioning (payer) functions, its major transformation programmes in cancer, mental health, learning disabilities and primary care and the move away from payment by results (fee for service) to health system based population health management. Before joining NHS England, Matthew was a Senior Vice President with the world’s largest dedicated healthcare IT company, Cerner, based in the USA.
Starting his career in the NHS as a graduate trainee Matthew moved on to be first CIO and then General Manager for women and children's services in a major teaching hospital. He was then Chief Operating Officer for a large general hospital, which won the Acute Hospital of the Year award and later Chief Executive for a general hospital and cancer centre, where he led its turnaround from one of the poorest performing hospitals in the NHS to one of the best.
Matthew has spent two periods in government, one as the head of the health advisory team in the Cabinet Officer, directly advising Tony Blair as Prime Minister, and then as the Senior Policy Adviser to the Secretary of State for Health. Matthew ended this role when Tony Blair stepped down and became the NHS's first National Chief Information Officer.
Matthew also writes for the Health Service Journal, is a member of the University Council at Hull University, a Visiting Professor at Surrey University, and a member of the Editorial Board for the Journal of Population Health Management.
Dr Paul Thompson
Dr Paul Thompson is the Vice-Chancellor of the Royal College of Art, the world’s oldest art school in continuous operation, and the only art and design university in the UK operating exclusively at postgraduate level. In 2015, 2016 and 2017, the RCA was ranked the world’s number one art and design university in the QS World University Rankings.
Prior to 2009, Paul was Director of the Smithsonian’s Cooper-Hewitt, National Design Museum in New York from 2001-2009. He was Director of the Design Museum in London from 1993-2001 and was educated at the Universities of Bristol and East Anglia. He is an Adjunct Professor at the Innovation in Global Health Institute, Imperial College London, a Trustee of the Victoria & Albert Museum and is on the Ashmolean Museum Board of Visitors.
Dr Agis Tsouros
Dr Tsouros is a leading international expert with 30 years of experience in the fields of health promotion, policy and systems and is well known internationally for his innovative work, his public health leadership and his diplomatic and communication skills. As former Director of the Division of Policy and Governance for Health and Wellbeing at the WHO Regional Office for Europe, he was responsible for the implementation of the new European Health Policy - Health 2020 and had leadership responsibility for a range of areas, including health policies; co-ordination and reform of the country health department; urban health and healthy cities; health promotion, healthy ageing and public health functions and infrastructures. During the period 2004 to 2006 he was seconded to the Greek Ministry of Health and assumed the position of Chairman of the National Board of Public Health and President of the Greek CDC. He is the author of many influential publications, which and have been translated into many languages worldwide. Dr Tsouros has collaborated with all 53 countries of the European region and worked in close cooperation with several directorates-general including those of the European Commission and the Council of Europe.
Sir Andrew Whitty
Andrew became Chief Executive Officer of GlaxoSmithKline plc on 21 May 2008. He is a member of the Board and Corporate Executive Team.
Andrew joined Glaxo in 1985 and has held a variety of Sales and Marketing roles in the UK and abroad including working in the Company’s International New Products groups, both in the Respiratory and HIV/Infectious disease fields. Outside of the UK Andrew has worked in South Africa, the USA and Singapore where he led the Group’s operations as Senior Vice President, Asia Pacific. While in Singapore Andrew was a Board Member of the Singapore Economic Development Board and the Singapore Land Authority. In 2003 he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star.
In 2003 Andrew was appointed President of GSK Europe and joined GSK’s Corporate Executive Team.
Andrew has served in numerous advisory roles to Governments around the world including South Africa, Singapore, Guangzhou China and the UK, where he was a member of the Prime Minister’s Business Advisory Group from 2010 - 2015. He was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry in the 2012 New Year Honours List. In 2014, Andrew was appointed to be a Business Ambassador for the UK Government and in 2015, Andrew became a member of the China-Britain Business Council Advisory Council.
Andrew is Chancellor of the University of Nottingham, a position he took up on 1 January 2013.
Andrew has a Joint Honours BA in Economics from the University of Nottingham.
Dr Suzette Woodward
Dr Suzette Woodward
Dr Suzette Woodward is a National Director of Sign up to Safety working for the Department of Health and Social Care in England. She specialised in paediatric intensive care nursing before moving into patient safety roles which have led her to be the Board Director of the National Patient Safety Agency and NHS Resolution. She has a Masters in Clinical Risk from UCL and a Doctorate in Patient Safety. Dr Woodward has over 20 years of experience of patient safety policy at a national level and has led many large scale change programmes and campaigns. Her current focus is delivering the current policy agenda to spread a just culture across the NHS and beyond.